| Total (n = 300) | Severe sepsis (n = 98) | Septic shock (n = 202) | p |
Male gender, n (%) | 178 (59) | 62 (60) | 116 (59) | 0.826* |
Age, mean ± SD | 59 ± 17 | 54 ± 18 | 61 ± 17 | 0.002£ |
SAPS II, mean ± SD | 48 ± 16 | 40 ± 13 | 52 ± 15 | <0.001£ |
Comorbidities, n (%) | 89 (30) | 26 (25) | 63 (32) | 0.225* |
Immunossupression | 24 (8) | 6 (6) | 18 (9) | 0.315* |
Chronic hepatic disease | 10 (4) | 3 (3) | 10 (5) | 0.553& |
Chronic renal disease | 23 (8) | 5 (5) | 18 (9) | 0.186* |
Chronic heart failure | 18 (6) | 7 (7) | 11 (6) | 0.675* |
Chronic respiratory disease | 22 (7) | 10 (10) | 12 (6) | 0.254* |
Haematologic disease | 5 (2) | 0 (0) | 5 (3) |
|
Cancer | 5 (2) | 0 (0) | 5 (3) |
|
Source of infection, n (%) |
|
|
|
|
Respiratory | 171 (57) | 67 (65) | 104 (53) | 0.042* |
Intra-abdominal | 69 (23) | 20 (19) | 49 (25) | 0.286* |
Urinary | 24 (8) | 3 (3) | 21 (11) | 0.023& |
Skin and soft tissue | 12 (4) | 58 (18) | 94 (22) | 0.225* |
Other | 24 (8) | 8 (8) | 16 (8) | 0.914* |
Microbiological documented, n (%) | 168 (56) | 53 (52) | 115 (58) | 0.252* |
Positive blood cultures, n (%) | 59 (20) | 13 (13) | 46 (23) | 0.026* |
Type of microorganism, n (%) |
|
|
| 0.474& |
Gram positive | 71 (42) | 23 (46) | 48 (41) |
|
Gram negative | 62 (37) | 15 (30) | 47 (40) |
|
Other | 35 (21) | 12 (24) | 23 (20) |
|
ESKAPE | 19 (11) | 5 (10) | 14 (12) | 1.000& |
Polimicrobian | 20 (4) | 8 (10) | 12 (7) | 0.050* |
ICU LOS, median (IQR) | 8 (3 - 15) | 6 (3 - 11) | 9 (3 - 16) | 0.001# |
Hospital LOS, median (IQR) | 16 (7 - 27) | 15 (8 - 24) | 16 (5 - 28) | 0.451# |
Death in ICU, n (%) | 100 (33) | 15 (15) | 85 (43) | <0.001* |
Death in hospital, n (%) | 111 (37) | 21 (20) | 90 (46) | <0.001* |